Daiki Miki Selected Research

Fluorouracil (Carac)

4/2008	Systemic gemcitabine combined with intra-arterial low-dose cisplatin and 5-fluorouracil for advanced hepatocellular carcinoma: seven cases.
11/2007	Similar effects of recombinant interferon-alpha-2b and natural interferon-alpha when combined with intra-arterial 5-fluorouracil for the treatment of advanced hepatocellular carcinoma.
10/2007	Pretreatment predictor of response, time to progression, and survival to intraarterial 5-fluorouracil/interferon combination therapy in patients with advanced hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daiki Miki Research Topics

Disease

41	Infections 01/2023 - 06/2009
35	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 10/2007
26	Chronic Hepatitis C 01/2021 - 09/2010
16	Liver Cirrhosis (Hepatic Cirrhosis) 03/2024 - 09/2010
15	Chronic Hepatitis B 01/2022 - 08/2010
14	Fibrosis (Cirrhosis) 03/2024 - 01/2008
13	Neoplasms (Cancer) 11/2023 - 10/2007
7	Hepatitis B 01/2023 - 03/2015
5	Liver Diseases (Liver Disease) 01/2023 - 09/2010
5	Hepatitis C 12/2014 - 07/2011
4	Hepatic Encephalopathy 09/2023 - 03/2018
4	Non-alcoholic Fatty Liver Disease 04/2023 - 02/2018
4	Hepatitis 01/2021 - 10/2013
3	Inflammation (Inflammations) 01/2023 - 09/2010
3	Chronic Hepatitis (Chronic Active Hepatitis) 01/2020 - 03/2017
3	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 05/2017 - 08/2012
2	Virus Diseases (Viral Diseases) 03/2024 - 03/2015
2	Portal Hypertension 03/2024 - 11/2020
2	Fatigue 11/2023 - 11/2014
2	Acute-On-Chronic Liver Failure 10/2023 - 10/2023
2	Body Weight (Weight, Body) 01/2023 - 04/2008
2	Disease Progression 07/2019 - 03/2015
2	Ventricular Fibrillation 01/2016 - 04/2013
2	Anemia 07/2011 - 06/2011
2	Thrombosis (Thrombus) 11/2007 - 10/2007
1	Overweight 02/2024
1	Proteinuria 11/2023
1	Anorexia 11/2023
1	Hypertension (High Blood Pressure) 11/2023
1	Neoplasm Metastasis (Metastasis) 11/2023
1	Pain (Aches) 11/2023
1	Acute Liver Failure (Fulminant Hepatic Failure) 09/2023

Drug/Important Bio-Agent (IBA)

30	InterferonsIBA 01/2021 - 10/2007
21	Antiviral Agents (Antivirals)IBA 12/2023 - 09/2013
20	Ribavirin (Virazole)FDA LinkGeneric 01/2020 - 09/2010
11	daclatasvirIBA 01/2020 - 01/2014
10	asunaprevirIBA 01/2020 - 01/2015
8	Bevacizumab (Avastin)FDA Link 03/2024 - 01/2018
8	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2009
8	lenvatinibIBA 11/2023 - 01/2020
7	atezolizumabIBA 03/2024 - 01/2023
7	AntigensIBA 01/2021 - 01/2009
6	CytokinesIBA 09/2023 - 09/2010
6	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021 - 01/2017
6	Proteins (Proteins, Gene)FDA Link 11/2020 - 01/2009
5	NucleotidesIBA 01/2023 - 10/2013
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2024 - 05/2016
4	SofosbuvirIBA 01/2021 - 11/2017
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 09/2015
4	RNA (Ribonucleic Acid)IBA 01/2020 - 07/2012
4	telaprevirIBA 12/2014 - 07/2011
3	nasIBA 03/2024 - 10/2013
3	Alanine Transaminase (SGPT)IBA 01/2023 - 06/2009
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023 - 07/2012
3	Immunoglobulin G (IgG)IBA 01/2022 - 02/2018
3	Circulating Tumor DNAIBA 06/2021 - 09/2015
3	ChemokinesIBA 07/2019 - 01/2011
3	NucleosidesIBA 01/2019 - 01/2018
3	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 05/2017 - 08/2012
3	Complementary DNA (cDNA)IBA 05/2017 - 01/2009
3	Interferon LambdaIBA 09/2015 - 02/2011
3	MicroRNAs (MicroRNA)IBA 03/2015 - 01/2012
3	Fluorouracil (Carac)FDA LinkGeneric 04/2008 - 10/2007
2	Alkaline PhosphataseIBA 03/2024 - 10/2019
2	Zoledronic Acid (Zometa)FDA Link 11/2023 - 03/2015
2	Interleukin-6 (Interleukin 6)IBA 10/2023 - 10/2023
2	Interleukin-8 (Interleukin 8)IBA 09/2023 - 12/2018
2	Prothrombin (Factor II)IBA 09/2023 - 01/2021
2	LipidsIBA 01/2023 - 11/2017
2	Hemoglobins (Hemoglobin)IBA 01/2023 - 06/2011
2	Amino Acids FDA Link 01/2022 - 02/2011
2	velpatasvirIBA 01/2021 - 11/2020
2	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 11/2016
2	HLA-DQB1 antigen (HLA DQB1)IBA 12/2020 - 01/2013
2	Fetal Proteins (Fetoprotein)IBA 11/2020 - 01/2018
2	EnzymesIBA 01/2020 - 10/2019
2	ledipasvirIBA 12/2018 - 11/2017
2	entecavir FDA Link 12/2018 - 01/2018
2	Hepatitis B e AntigensIBA 01/2018 - 10/2013
2	Sorafenib (BAY 43-9006)FDA Link 01/2018 - 01/2018
2	HMGB1 Protein (HMG1)IBA 01/2018 - 01/2018
2	SimeprevirIBA 03/2017 - 12/2016
2	Protease Inhibitors (Protease Inhibitor)IBA 12/2016 - 11/2014
2	HLA-DP Antigens (HLA-DP)IBA 12/2015 - 10/2011
2	HLA-DQ Antigens (HLA-DQ)IBA 01/2013 - 10/2011
2	Guanosine Triphosphate (GTP)IBA 07/2012 - 09/2010
1	Denosumab FDA Link 11/2023
1	collagen type I trimeric cross-linked peptideIBA 11/2023
1	Collagen Type I (Type I Collagen)IBA 11/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2023
1	Interleukin-4 (Interleukin 4)IBA 09/2023
1	Chloroform (Trichloromethane)IBA 04/2023
1	Blood Glucose (Blood Sugar)IBA 01/2023
1	SodiumIBA 01/2023

Therapy/Procedure

52	Therapeutics 03/2024 - 10/2007
7	Liver Transplantation 09/2023 - 11/2011
4	Drug Therapy (Chemotherapy) 01/2018 - 04/2008
3	Hepatectomy 01/2022 - 12/2014
2	Aftercare (After-Treatment) 10/2023 - 01/2023
1	Activities of Daily Living (ADL) 11/2023